Clinical trial IJB_2655
A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 versus Treatment of Physician's Choice (TPC) in Patients with Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated with an Anthracycline, a Taxane, and Capecitabine
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Nektar Therapeutics |
| EudraCT Identifier | 2016-002453-38 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02915744 |
| Inclusion criteria | after two lines RECIST 1.1 |
| Last update |